Ono Pharmaceutical Co., Ltd. (OPHLF)
OTCMKTS · Delayed Price · Currency is USD
16.30
-0.25 (-1.48%)
Feb 11, 2026, 4:00 PM EST
Ono Pharmaceutical Employees
Ono Pharmaceutical had 4,287 employees as of March 31, 2025. The number of employees increased by 434 or 11.26% compared to the previous year.
Employees
4,287
Change (1Y)
434
Growth (1Y)
11.26%
Revenue / Employee
$757,785
Profits / Employee
$92,842
Market Cap
7.76B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,287 | 434 | 11.26% |
| Mar 31, 2024 | 3,853 | 92 | 2.45% |
| Mar 31, 2023 | 3,761 | 74 | 2.01% |
| Mar 31, 2022 | 3,687 | 80 | 2.22% |
| Mar 31, 2021 | 3,607 | 47 | 1.32% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Tian'an Technology Group | 8 |
| OpGen | 1 |
Ono Pharmaceutical News
- 9 days ago - Ono Pharmaceutical (OPHLF) Reports Strong Nine-Month Financial Results - GuruFocus
- 10 days ago - Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook - Seeking Alpha
- 10 days ago - Ono Pharmaceutical Co. Ltd. Reveals Climb In Nine Months Bottom Line - Nasdaq
- 27 days ago - Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 4 weeks ago - Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Ono Pharma Taiwan Receives Additional Approval Of Opdivo In Combination With Ipilimumab - Nasdaq
- 5 weeks ago - Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical - GlobeNewsWire
- 2 months ago - Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting - Business Wire